AbbVie Share Buybacks increased by 49533.3% to $1.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.9%, from $961.00M to $1.49B. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows relatively stable performance with a 1.2% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.00M | $6.00M | $131.00M | $1.47B | $9.00M | $4.00M | $4.00M | $1.96B | $10.00M | $4.00M | $3.00M | $1.32B | $9.00M | $17.00M | $358.00M | $961.00M | $12.00M | $4.00M | $3.00M | $1.49B |
| QoQ Change | — | -40.0% | >999% | >999% | -99.4% | -55.6% | +0.0% | >999% | -99.5% | -60.0% | -25.0% | >999% | -99.3% | +88.9% | >999% | +168.4% | -98.8% | -66.7% | -25.0% | >999% |
| YoY Change | — | — | — | — | -10.0% | -33.3% | -96.9% | +33.0% | +11.1% | +0.0% | -25.0% | -32.3% | -10.0% | +325.0% | >999% | -27.4% | +33.3% | -76.5% | -99.2% | +54.9% |